Gender peculiarities of critical lower limb ischemia

Abstract

BACKGROUND: Development of critical ischemia of lower limbs in patients with atherosclerosis causes negative consequences due to the high probability of detecting multilevel changes, as well as identifying coronary and carotid pools.

АIM: The aim of the study was to investigate gender differences in critical lower limb ischemia of atherosclerotic genesis following reconstructive interventions.

MATERIALS AND METHODS: Arterial reconstructions have been performed in 261 patients with peripheral atherosclerosis (95 women and 166 men). The specific features of reconstructive interventions have been taken into account; complications and the number of amputations have been analyzed in the early period.

RESULTS: Higher pulse pressure has been registered in the female group; tibial arteries have been affected significantly more frequently (p < 0,05). Thrombosis of the operated segment has been observed more frequently in the male patients at the stage of critical ischemia; in the case of claudication the complications were sporadic.

CONCLUSIONS: The best results of reconstructive care in men and women with peripheral atherosclerosis at the claudication stage determine the vector of active tactics in the absence of conservative treatment results.

Keywords

peripheral atherosclerosis / critical ischemia / gender differences

References

[1] Krishna SM, Moxon JV, Golledge J. A Review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16(5):11294–11322. DOI: 10.3390/ijms160511294

[2] Krishna S.M., Moxon J.V., Golledge J. A Review of the pathophysiology and potential biomarkers for peripheral artery disease // Int. J. Mol. Sci. 2015. Vol.16, No. 5. P. 11294–11322. DOI: 10.3390/ijms160511294

[3] Matsushita K, Kwak L, Yang C, et al. High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study. Eur Heart J. 2018;39(25):2412–2419. DOI: 10.1093/eurheartj/ehy106

[4] Matsushita K., Kwak L.,Yang C. et al. High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study // Eur. Heart J. 2018. Vol. 39, No. 25. P. 2412–2419. DOI: 10.1093/eurheartj/ehy106

[5] Puzdriak PD, Shlomin VV, Bondarenko PB, et al. Comparison of the results of hybrid and open surgical treatment of multilevel arterial disease of lower extremities (in Russian only). Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(3):227–234. (In Russ.). DOI: 10.17116/kardio201912031227

[6] Пуздряк П.Д., Шломин В.В., Бондаренко П.С. и др. Сравнение результатов гибридного и открытого хирургического лечения многоуровневого поражения артерий нижних конечностей // Кардиология и сердечно-сосудистая хирургия. 2019. Т. 12, № 3. С. 227–234. DOI: 10.17116/kardio201912031227

[7] Glushkov NI, Potashov TA, Ivanov MA, et al. Optimal terms of revascularization in patients with peripheral atherosclerosis Preventive and Clinical Medicine. 2020;3(76):70–76. (In Russ.)

[8] Глушков Н.И., Поташов Т.А., Иванов М.А. и др. К вопросу об оптимальных сроках реваскуляризации у лиц с периферическим атеросклерозом // Профилактическая и клиническая медицина. 2020. Т. 3, № 76. С. 70–76.

[9] Man JJ, Beckman JA, Jaffe IZ. Sex as a biological variable in atherosclerosis. Circ Res. 2020;126(9):1297–1319. DOI: 10.1161/CIRCRESAHA.120.315930

[10] Man J.J., Beckman J.A., Jaffe I.Z. Sex as a biological variable in atherosclerosis // Circ. Res. 2020. Vol. 126, No. 9. P. 1297–1319. DOI: 10.1161/CIRCRESAHA.120.315930

[11] Jelani Q, Mena-Hurtado C, Burg M, et al. Relationship between depressive symptoms and health status in peripheral artery disease: role of sex differences. J Am Heart Assoc. 2020;9(16):e014583. DOI: 10.1161/JAHA.119.014583

[12] Jelani Q., Mena-Hurtado C., Burg M. et al. Relationship between depressive symptoms and health status in peripheral artery disease: role of sex differences // J. Am. Heart Assoc. 2020. Vol. 9, No. 16. P. e014583. DOI: 10.1161/JAHA.119.014583

[13] Pérez-López FR, Larrad-Mur L, Kallen A, et al. Differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010;17(6):511–531. DOI: 10.1177/1933719110367829

[14] Pérez-López F.R., Larrad-Mur L., Kallen A. et al. Differences in cardiovascular disease: hormonal and biochemical influences // Reprod. Sci. 2010. Vol. 17, No. 6. P. 511–531. DOI: 10.1177/1933719110367829

[15] Fanlo-Maresma M, Candás-Estébanez B, Esteve-Luque V, et al. Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupus. J Clin Med. 2021;10(10):2218. DOI: 10.3390/jcm10102218

[16] Fanlo-Maresma M., Candás-Estébanez B., Esteve-Luque V. et al. Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupus // J. Clin. Med. 2021. Vol. 10, No. 10. P. 2218. DOI: 10.3390/jcm10102218

[17] Giannopoulos S, Shammas NW, Cawich I, et al. Sex-Related Differences in the Outcomes of endovascular interventions for chronic limb-threatening ischemia: results from the liberty 360 study. Vasc Health Risk Manag. 2020;16:271–284. DOI: 10.2147/VHRM.S246528

[18] Giannopoulos S., Shammas N.W., Cawich I. et al. Sex-Related Differences in the Outcomes of endovascular interventions for chronic limb-threatening ischemia: results from the liberty 360 study // Vasc. Health Risk Manag. 2020. Vol. 16. P. 271–284. DOI: 10.2147/VHRM.S246528

[19] Altreuther M, Mattsson E. Long-term results after femoral thrombendarterectomy combined with simultaneous endovascular intervention in intermittent claudication and critical ischemia. SAGE Open Med. 2020;8:2050312119900860. DOI: 10.1177/2050312119900860

[20] Altreuther M., Mattsson E. Long-term results after femoral thrombendarterectomy combined with simultaneous endovascular intervention in intermittent claudication and critical ischemia // SAGE Open Med. 2020. Vol. 8. P. 2050312119900860. DOI: 10.1177/2050312119900860

[21] Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg. 2001;33(2):251–257. DOI: 10.1067/mva.2001.112210

[22] Muluk S.C., Muluk V.S., Kelley M.E. et al. Outcome events in patients with claudication: a 15-year study in 2777 patients // J. Vasc. Surg. 2001. Vol. 33, No. 2. P. 251–257. DOI: 10.1067/mva.2001.112210

RIGHTS & PERMISSIONS

Glushkov N.I., Puzdriak P.D., Agurbash A.N., Razepin A.V., Ivanov M.A.